No abstract available
MeSH terms
-
Aging
-
BRCA1 Protein / genetics
-
BRCA2 Protein / genetics
-
Biomarkers, Tumor / metabolism
-
Breast Neoplasms / diagnosis*
-
Breast Neoplasms / epidemiology
-
Breast Neoplasms / therapy*
-
Breast Neoplasms, Male / epidemiology
-
Carcinoma in Situ / diagnosis
-
Carcinoma in Situ / epidemiology
-
Carcinoma in Situ / therapy
-
Chemotherapy, Adjuvant
-
Early Detection of Cancer / methods*
-
Europe / epidemiology
-
Female
-
Follow-Up Studies
-
Humans
-
Ki-67 Antigen / metabolism
-
Lymphatic Metastasis / diagnosis
-
Male
-
Mastectomy, Segmental / methods*
-
Neoplasm Recurrence, Local / therapy
-
Neoplasm Staging
-
Radiotherapy, Adjuvant
-
Receptor, ErbB-2 / metabolism
-
Receptors, Estrogen / metabolism
-
Receptors, Progesterone / metabolism
-
Risk Assessment
Substances
-
BRCA1 Protein
-
BRCA1 protein, human
-
BRCA2 Protein
-
BRCA2 protein, human
-
Biomarkers, Tumor
-
Ki-67 Antigen
-
Receptors, Estrogen
-
Receptors, Progesterone
-
ERBB2 protein, human
-
Receptor, ErbB-2